eMedicine Specialties > Sports Medicine > Introductory Topics in Sports Medicine

Female Athlete Triad: Follow-up

Author: Laura M Gottschlich, DO, Assistant Professor of Family and Community Medicine, Medical College of Wisconsin; Consulting Staff, St. Joseph Family Medicine Residency Program
Coauthor(s): Craig C Young, MD, Professor, Departments of Orthopedic Surgery and Community and Family Medicine, Medical Director of Sports Medicine, Sports Medicine Fellowship Director, Medical College of Wisconsin; Boone Barrow, MD, Consulting Staff, Department of Family Medicine, Scott and White Clinic
Contributor Information and Disclosures

Updated: May 30, 2008

Follow-up

Return to Play

In mild to moderate cases of the female athlete triad, many athletes continue to participate in their activity even while in treatment. Activity modifications should be in place, however, and the time that the patient spends exercising should be closely monitored. When inquiring about exercise times, the physician should ask about formal practice sessions as well as exercise away from the structured environment. Often, the extra activity burns much of the athlete's caloric intake.

When the physician discusses exercise restrictions, the athlete often finds it easier to accept a restriction of her private workouts rather than her practice time with a team or coach. As with anorexia and bulimia, the triad is a secretive disorder. Just as the athlete may want to hide evidence of the disease, she may also try to hide evidence of the treatment. By allowing her to continue activity with her peers or coaches, she may not resist treatment.

Unless necessary, withdrawal from activity should not be used as a form of punishment for noncompliance or lack of objective improvement. This can often result in loss of the trust that has been built up between the clinician and athlete and can lead to the athlete's resumption of self-directed exercise. Instead, the physician should work with the athlete to try to make her understand the necessity of the restrictions that are being set. This should minimize the likelihood of the athlete stopping therapy or being lost to follow-up.

If the athlete has been restricted from athletics because of poor compliance with the proscribed regimen or due to physical limitation (eg, stress fracture), a slow resumption of exercise should be attempted. In advanced or difficult cases, resumption of activity should not be allowed until the athlete is within 10-15% of the suggested body weight. Even in cases in which the athlete meets the weight goal, only slow resumption should be attempted. If a physical limitation is required (eg, to let a stress fracture heal), the limitation may be needed for longer than usual to permit complete healing in the osteoporotic bone.

Complications

Continued bone loss leading to irreversible osteoporosis is the most worrisome complication of the triad. Some evidence exists to suggest that BMD can be regained to a small degree, but it is doubtful that a significant loss can be completely corrected, even with years of therapy.

Multiple stress fractures or complete fractures can, of course, lead to increased incidence of osteoarthritis, depending on the site of the fractures. Other fractures may heal without any long-term sequelae. Careful monitoring of these fractures should be provided, as they may take longer to heal than one would expect. The negative nutritional balance often leads to slowed or delayed healing of fractures.

End-stage eating disorders can result in more serious complications, such as prolonged hospitalization, cardiac arrhythmias, or even death. Anorexia nervosa has an estimated mortality rate of 15% once the diagnosis is made. Compared with other individuals, athletes are less likely to meet the criteria for anorexia or bulimia, but significant morbidity and mortality can occur.

Prevention

Because of the difficulty in diagnosing the female athlete triad and in treating patients with the condition, prevention is fundamental in reducing morbidity and mortality rates. Early detection reduces symptoms and decreases the likelihood of serious long-term consequences.

There is substantial debate between physicians and the coaching community regarding the role of weigh-ins for sports. Some coaches or instructors have strict guidelines based on height or body type, and they set maximal weights for eligibility for competition. This regimented approach often places increased stress on the athlete and sends the wrong message about the importance of weight. It also does not account for how well the athlete has been performing in her sport (eg, a situation in which the best athlete on the team is also 5 lb over the weight limit).

The situation can be made worse when overweight athletes are "punished" with running or performing push-ups or when they are forced to weigh in in front of the team. As a beginning step, the team physician should discourage such public weigh-ins and punishment and emphasize specific athletic achievement instead of weight.

The preparticipation physical examination presents an ideal opportunity to screen all female athletes for signs or symptoms of the triad. A high index of suspicion should be maintained for all female athletes because of the difficulty in diagnosing this disease. Many preparticipation questionnaires now include questions concerning the athlete's menstrual history and contentment with her current body weight. These questions often bring otherwise asymptomatic individuals to the attention of the medical and training staff. If these questions are not a part of the questionnaire, the physician should consider making them part of his or her routine examination. Most women will not volunteer this information unless asked; therefore, a proactive approach should be used in routine history taking.

Better education of team physicians, other healthcare providers, trainers, coaches, parents, and the athletes themselves should reduce the yearly incidence of the female athlete triad. Many young women consider oligomenorrhea or amenorrhea during the season or at times of peak activity a sign of hard work and dedication. Not long ago, the medical community considered athletic amenorrhea a benign condition and treated it as such. If both the athlete and physician are aware of the potential damage that can occur as a result of menstrual dysfunction, they may be able to prevent this insidious disease.

Prognosis

For many athletes, the long-term prognosis is good. Few athletes with the female athlete triad are admitted to the hospital for inpatient treatment, and few die from their disease. However, significant long-term morbidity may affect these women later in life.

The diagnosis of the female athlete triad was established in the early 1990s, and this constellation of symptoms had been noted for years before a name was given to it.3,20,22,23 However, no long-term data about future problems are available. The first generation of athletes in whom this condition was diagnosed is still years away from menopause. Therefore, whether osteoporosis that occurs at a younger age affects mortality or leads to more advanced osteoporosis later in life or an increased risk of significant fractures (eg, hip fractures) is unknown.

For mild to moderate cases of the female athlete triad, some improvement in bone health is thought to occur. The lost BMD is unlikely to be replaced in its entirety, and the bone mass that should have been accumulated during this important time in bone development may or may not be regained. However, many case reports show that bone density does not increase, and the losses may be permanent. Unfortunately, no long-term, double-blinded, controlled studies are available (and cannot be performed).

As more information about the female athlete triad and its complications is gathered, everyone involved may better understand the significant morbidity that can occur years or decades after the disease is diagnosed and treated.

Education

Educating athletes may lead to earlier detection of the female athlete triad. If women know that amenorrhea is not a positive sign of hard work but a harbinger of disease, they may seek treatment sooner. Of course, the triad has a secretive nature, and once an athlete is showing signs of disordered eating, education may not be enough to help these women seek help. If the general athletic population is aware of the signs and symptoms of this disease, the female athlete triad might be caught in its early stages.

Physicians need to do better in educating trainers, coaches, and parents (as well as the athletes themselves). These are the people who will have daily contact with the athlete, and they may be the persons who first raise concerns about a particular individual. Taking the time to talk to the athletic staff about the warning signs may help in preventing the disease or catching it in its early stages.

Related eMedicine topics:
Amenorrhea
Eating Disorder: Anorexia
Eating Disorder: Bulimia
Menstruation Disorders
Stress Fractures

Related Medscape topics:
Resource Center Eating Disorders
Resource Center Exercise and Sports Medicine
Resource Center Nutrition
CME Bone Density Evaluation in Teens Prevents Future Osteoporosis
The Female Athlete Triad: Do Female Athletes Need to Take Special Care to Avoid Low Energy Availability

Miscellaneous

Medicolegal Pitfalls

  • The main medicolegal complication is most likely the failure to diagnose the female athlete triad in a timely manner.
  • Because the diagnosis was formalized in the past decade or so, the direction the legal community has decided to take regarding the triad is still being established.
  • Medical malpractice suits are likely to follow patterns established in the diagnosis of anorexia and bulimia.
  • Although the diagnosis of the female athlete triad is relatively new, legal-civil penalties could be harsh because of the severity of the disease and the population it affects.
  • As with most diseases, timely diagnosis and initiation of treatment is paramount in avoiding lawsuits. Diagnosis of the female athlete triad can be delayed because the stress fracture is diagnosed first, followed by the amenorrhea and, lastly, the eating disorder.
  • What may make civil litigation difficult are the secretive nature of the disease and the significant rate of patient noncompliance with treatment.
  • Even with rapid diagnosis and treatment, bad outcomes are possible.

Related Medscape topic:
Resource Center Medical Malpractice and Legal Issues

Special Concerns

  • The female athlete triad affects a specific subpopulation, and as such, this disease poses a few special concerns to consider.
  • Pregnancy is usually not an issue because of the amenorrhea involved with the triad. If the athlete is lacking this portion of the triad, pregnancy is still unlikely because of the physical and nutritional stresses she is experiencing. If the athlete does become pregnant while exhibiting other signs of the triad, a more aggressive treatment approach must be pursued in decreasing her activity levels and in addressing her nutritional changes.
  • The female athlete triad rarely affects women older than 40-50 years. By far, most women are affected in their early teens to late 20s. This disease is simply not one that affects the geriatric population. It can, however, affect girls who have not yet experienced menarche. In these patients, differentiating primary amenorrhea from congenital abnormalities or hormonal imbalances during the initial workup becomes significantly more important.

Related Medscape topics:
Resource Center Adolescent Medicine
Specialty Site Women's Health

 


More on Female Athlete Triad

Overview: Female Athlete Triad
Differential Diagnoses & Workup: Female Athlete Triad
Treatment & Medication: Female Athlete Triad
Follow-up: Female Athlete Triad
References

References

  1. Beals KA, Meyer NL. Female athlete triad update. Clin Sports Med. Jan 2007;26(1):69-89. [Medline].

  2. Templeton KJ, Hame SL, Hannafin JA, et al. Sports injuries in women: sex- and gender-based differences in etiology and prevention. Instr Course Lect. 2008;57:539-52. [Medline].

  3. American College of Sports Medicine. The female athlete triad: disordered eating, amenorrhea, osteoporosis -- a call to action. Sports Med Bull. 1992;27:4.

  4. Brunet M 2nd. Female athlete triad. Clin Sports Med. Jul 2005;24(3):623-36, ix. [Medline].

  5. Otis CL, Drinkwater B, Johnson M, Loucks A, Wilmore J. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc. May 1997;29(5):i-ix. [Medline].

  6. Burrows M, Shepherd H, Bird S, MacLeod K, Ward B. The components of the female athlete triad do not identify all physically active females at risk. J Sports Sci. Oct 2007;25(12):1289-97. [Medline].

  7. Nattiv A, Loucks AB, Manore MM, et al. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc. Oct 2007;39(10):1867-82. [Medline].

  8. De Souza MJ, Williams NI. Beyond hypoestrogenism in amenorrheic athletes: energy deficiency as a contributing factor for bone loss. Curr Sports Med Rep. Feb 2005;4(1):38-44. [Medline].

  9. Shangold M, Rebar RW, Wentz AC, Schiff I. Evaluation and management of menstrual dysfunction in athletes. JAMA. Mar 23-30 1990;263(12):1665-9. [Medline].

  10. The Writing Group for the International Society for Clinical Densitometry (ISCD) Position Development Conference. Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom. Spring 2004;7(1):17-26. [Medline].

  11. Rosen LW, Hough DO. Pathogenic weight-control behavior of female college gymnasts. Phys Sportsmed. 1988;16(9):141-6.

  12. Kiernan M, Rodin J, Brownell KD, Wilmore JH, Crandall C. Relation of level of exercise, age, and weight-cycling history to weight and eating concerns in male and female runners. Health Psychol. 1992;11(6):418-21. [Medline].

  13. Sabatini S. The female athlete triad. Am J Med Sci. Oct 2001;322(4):193-5. [Medline].

  14. Sanborn CF, Horea M, Siemers BJ, Dieringer KI. Disordered eating and the female athlete triad. Clin Sports Med. Apr 2000;19(2):199-213. [Medline].

  15. Bonci CM, Bonci LJ, Granger LR, et al. National athletic trainers' association position statement: preventing, detecting, and managing disordered eating in athletes. J Athl Train. Jan-Mar 2008;43(1):80-108. [Medline][Full Text].

  16. Lebrun CM. The female athlete triad: what's a doctor to do?. Curr Sports Med Rep. Dec 2007;6(6):397-404. [Medline].

  17. Nichols JF, Rauh MJ, Lawson MJ, Ji M, Barkai HS. Prevalence of the female athlete triad syndrome among high school athletes. Arch Pediatr Adolesc Med. Feb 2006;160(2):137-42. [Medline].

  18. Waldrop J. Early identification and interventions for female athlete triad. J Pediatr Health Care. Jul-Aug 2005;19(4):213-20. [Medline].

  19. Loucks AB. Effects of exercise training on the menstrual cycle: existence and mechanisms. Med Sci Sports Exerc. Jun 1990;22(3):275-80. [Medline].

  20. Wilmore JH. Eating and weight disorders in the female athlete. Int J Sport Nutr. Jun 1991;1(2):104-17. [Medline].

  21. Brownell KD, Steen SN, Wilmore JH. Weight regulation practices in athletes: analysis of metabolic and health effects. Med Sci Sports Exerc. Dec 1987;19(6):546-56. [Medline].

  22. Skolnick AA. 'Female athlete triad' risk for women. JAMA. Aug 25 1993;270(8):921-3. [Medline].

  23. Nattiv A, Agostini R, Drinkwater B, Yeager KK. The female athlete triad. The inter-relatedness of disordered eating, amenorrhea, and osteoporosis. Clin Sports Med. Apr 1994;13(2):405-18. [Medline].

  24. Burckes-Miller ME, Black DR. Male and female college athletes: prevalence of anorexia nervosa and bulimia nervosa. J Athl Train. 1988;23(2):137-40.

  25. Di Pietro L, Stachenfeld N, Pierce JB. The female athlete triad revisited. Med Sci Sports Exerc. Sep 2005;37(9):1643; author reply 1644. [Medline].

  26. Drinkwater BL, Bruemner B, Chesnut CH 3rd. Menstrual history as a determinant of current bone density in young athletes. JAMA. Jan 26 1990;263(4):545-8. [Medline].

  27. Drinkwater BL, Nilson K, Chesnut CH 3rd, et al. Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med. Aug 2 1984;311(5):277-81. [Medline].

  28. Fagan KM. Pharmacologic management of athletic amenorrhea. Clin Sports Med. Apr 1998;17(2):327-41. [Medline].

  29. Frisch RE, Gotz-Welbergen AV, McArthur JW, et al. Delayed menarche and amenorrhea of college athletes in relation to age of onset of training. JAMA. Oct 2 1981;246(14):1559-63. [Medline].

  30. Frisch RE, McArthur JW. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science. Sep 13 1974;185(4155):949-51. [Medline].

  31. Loucks AB, Horvath SM. Athletic amenorrhea: a review. Med Sci Sports Exerc. Feb 1985;17(1):56-72. [Medline].

  32. Loucks AB, Nattiv A. Essay: the female athlete triad. Lancet. Dec 2005;366(suppl 1):S49-50. [Medline].

  33. NIH Consensus Development Panel on Optimal Calcium Intake. NIH Consensus conference. Optimal calcium intake. JAMA. Dec 28 1994;272(24):1942-8. [Medline].

  34. Otis CL. Exercise-associated amenorrhea. Clin Sports Med. Apr 1992;11(2):351-62. [Medline].

  35. Palla B, Litt IF. Medical complications of eating disorders in adolescents. Pediatrics. May 1988;81(5):613-23. [Medline].

  36. Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR. The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA. Mar 6 1991;265(9):1133-8. [Medline].

  37. Torstveit MK, Sundgot-Borgen J. The female athlete triad exists in both elite athletes and controls. Med Sci Sports Exerc. Sep 2005;37(9):1449-59. [Medline].

  38. Warren MP. The effects of exercise on pubertal progression and reproductive function in girls. J Clin Endocrinol Metab. Nov 1980;51(5):1150-7. [Medline].

  39. Warren MP, Brooks-Gunn J, Hamilton LH, Warren LF, Hamilton WG. Scoliosis and fractures in young ballet dancers. Relation to delayed menarche and secondary amenorrhea. N Engl J Med. May 22 1986;314(21):1348-53. [Medline].

  40. Warren MP, Perlroth NE. The effects of intense exercise on the female reproductive system. J Endocrinol. Jul 2001;170(1):3-11. [Medline].

Further Reading

Keywords

FAT, sports amenorrhea, sports-related amenorrhea, amenorrhea, female athletes, disordered eating, anorexia, bulimiaosteoporosis, energy availability, low energy availability in the female athlete, menstrual dysfunction, menstruation disorders, bone health, functional hypothalamic amenorrhea

Contributor Information and Disclosures

Author

Laura M Gottschlich, DO, Assistant Professor of Family and Community Medicine, Medical College of Wisconsin; Consulting Staff, St. Joseph Family Medicine Residency Program
Laura M Gottschlich, DO is a member of the following medical societies: American Academy of Family Physicians, American College of Sports Medicine, American Medical Association, American Medical Society for Sports Medicine, and American Osteopathic Association
Disclosure: Nothing to disclose.

Coauthor(s)

Craig C Young, MD, Professor, Departments of Orthopedic Surgery and Community and Family Medicine, Medical Director of Sports Medicine, Sports Medicine Fellowship Director, Medical College of Wisconsin
Craig C Young, MD is a member of the following medical societies: American Academy of Family Physicians, American College of Sports Medicine, American Medical Society for Sports Medicine, Phi Beta Kappa, and Wilderness Medical Society
Disclosure: Nothing to disclose.

Boone Barrow, MD, Consulting Staff, Department of Family Medicine, Scott and White Clinic
Boone Barrow, MD is a member of the following medical societies: American Academy of Family Physicians, American College of Sports Medicine, American Medical Association, American Medical Society for Sports Medicine, and Texas Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Leslie Milne, MD, Assistant Clinical Instructor, Department of Emergency Medicine, Harvard University School of Medicine
Leslie Milne, MD is a member of the following medical societies: American College of Sports Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Russell D White, MD, Professor of Medicine, Department of Community and Family Medicine, University of Missouri-Kansas City School of Medicine, Truman Medical Center Lakewood
Disclosure: Nothing to disclose.

CME Editor

Jon B Whitehurst, MD, Clinical Instructor of Surgery, University of Illinois College of Medicine; Partner and Executive Board Member, Rockford Orthopedic Associates; Orthopedic Chairman, Rockford Memorial Hospital
Jon B Whitehurst, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, and Arthroscopy Association of North America
Disclosure: Nothing to disclose.

Chief Editor

Craig C Young, MD, Professor, Departments of Orthopedic Surgery and Community and Family Medicine, Medical Director of Sports Medicine, Sports Medicine Fellowship Director, Medical College of Wisconsin
Craig C Young, MD is a member of the following medical societies: American Academy of Family Physicians, American College of Sports Medicine, American Medical Society for Sports Medicine, Phi Beta Kappa, and Wilderness Medical Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.